Acute Mesenteric IschemiaAMI_CATNCT06428240
Acute Mesenteric Ischemia, Reality in Catalonia
An observational study of Acute Mesenteric Ischemia, run by Hospital del Mar.
Trial summary
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality, the diagnostic and management is truly multidisciplinary, but not very extended. The aim of this study is to analyse the results of the patients admited with an AMI in Catalonia. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Mesenteric Ischemia
- How many people
- 50 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2024to 30 Apr 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study populations is all pacients with the diagnostic of Acute Mesenteric Ischemia that are admitted in the Hospital in Catalonia.
Who may be able to join
- Diagnostic of Acute Mesenteric Ischemia
Who cannot join
- Chronic Mesenteric Ischemia
- Ischemic Colitis
- Bowel obstruction strangulation
- Inflammatory bowel necrosis
About this study
Official title: Reality of Acute Mesenteric Ischemia in Catalonia, is There a Chance to Improvement?
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality, the diagnostic and management is truly multidisciplinary, but not very extended. The aim of this study is to analyse the results of the patients admited with an AMI in Catalonia.
Read the detailed description
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality from 50 to 80%. Even though AMI is a relatively rare condition (1:1,000) the incidence rises exponentially with increasing age, in patients older than 75 years, the incidence of AMI has been reported higher than that of acute appendicitis. AMI patients benefit from early assessment in a surgical unit with capabilities to definitive management. The diagnosis and management of AMI are truly multidisciplinary, requiring high index of suspicion and awareness from emergency department physicians, preferably computed tomography angiography with precise interpretation, but usually this is not the truth reality and the diagnostic is delayed as well as the treatment, and the management is not multidisciplinary.
The aim of this study is to analyse the management and results of the patients admitted with an AMI in Catalonia from November 2024 to April 2026.
- Conditions
- Acute Mesenteric Ischemia
- Keywords
- Mesenteric ischemia, Acute Mesenteric ischemia, Abdominal pain, Elderly, Complications, Mortality
- Medical subject headings
- Mesenteric Ischemia, Abdominal Pain
What is being measured
The primary outcome is the main question the study is designed to answer.
Mortality
To describe the mortality in patients with a diagnostic of AMI
Measured: 2024-2026
Secondary outcomes (2)
Complications
To describe the complications in patients with a diagnostic of AMI
Measured: 2024-2026
Management
To describe the management in patients with a diagnostic of AMI
Measured: 2024-2026
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2024
- Study start1 Nov 2024 (estimated)
- Primary completion1 Nov 2024 (estimated)
- Study completion30 Apr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Acute Mesenteric IschemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital del Mar
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital Clinic of Barcelona, Germans Trias i Pujol Hospital, Parc Taulí Hospital Universitari, Hospital de la Santa creu i Sant Pau - Barcelona, Hospital Vall d'Hebron, Hospital Universitari Joan XXIII de Tarragona., Hospital de Manresa, Hospital de Mataró, Hospital Universitari Sant Joan de Reus, Hospital de Sant Joan Despí Moisès Broggi, Hospital d'Igualada, Consorci Hospitalari de Vic, Hospital Arnau de Vilanova, Hospital de Mollet, Hospital de Terrassa, Hospital Universitari de Bellvitge
- Responsible party
- Principal investigator, Ana María González Castillo, Hospital del Mar
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06428240
- Sponsor's protocol ID
- AMICat Reality
- Acronym
- AMI_CAT
- Status last verified
- May 2024
- First submitted
- 20 May 2024
- Last updated
- 3 Jun 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Gonzalez-Castillo AM, Calsina Juscafresa L, Gelabert A, Velescu A, Marrano E, Vikatmaa P, Tolonen M. The real-world management of acute mesenteric ischemia in Spain: results from a multicenter national survey. Eur J Trauma Emerg Surg. 2026 May 19;52(1):167. doi: 10.1007/s00068-026-03209-1.
PubMed 42154050
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reality of Acute Mesenteric Ischemia in Catalonia, is There a Chance to Improvement?
- ClinicalTrials.gov ID
- NCT06428240
- Acronym / sponsor ID
- AMI_CAT / AMICat Reality
- Conditions
- Acute Mesenteric Ischemia
- Keywords
- Mesenteric ischemia, Acute Mesenteric ischemia, Abdominal pain, Elderly, Complications, Mortality
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Hospital del MarUniversity, hospital or other
- Collaborators
- Hospital Clinic of Barcelona, Germans Trias i Pujol Hospital, Parc Taulí Hospital Universitari, Hospital de la Santa creu i Sant Pau - Barcelona, Hospital Vall d'Hebron, Hospital Universitari Joan XXIII de Tarragona., Hospital de Manresa, Hospital de Mataró, Hospital Universitari Sant Joan de Reus, Hospital de Sant Joan Despí Moisès Broggi, Hospital d'Igualada, Consorci Hospitalari de Vic, Hospital Arnau de Vilanova, Hospital de Mollet, Hospital de Terrassa, Hospital Universitari de Bellvitge
- Study start
- 1 Nov 2024 (estimated)
- Primary completion
- 1 Nov 2024 (estimated)
- Study completion
- 30 Apr 2026 (estimated)
- First posted
- 24 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality, the diagnostic and management is truly multidisciplinary, but not very extended. The aim of this study is to analyse the results of the patients admited with an AMI in Catalonia.
Detailed description
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality from 50 to 80%. Even though AMI is a relatively rare condition (1:1,000) the incidence rises exponentially with increasing age, in patients older than 75 years, the incidence of AMI has been reported higher than that of acute appendicitis. AMI patients benefit from early assessment in a surgical unit with capabilities to definitive management. The diagnosis and management of AMI are truly multidisciplinary, requiring high index of suspicion and awareness from emergency department physicians, preferably computed tomography angiography with precise interpretation, but usually this is not the truth reality and the diagnostic is delayed as well as the treatment, and the management is not multidisciplinary.
The aim of this study is to analyse the management and results of the patients admitted with an AMI in Catalonia from November 2024 to April 2026.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study populations is all pacients with the diagnostic of Acute Mesenteric Ischemia that are admitted in the Hospital in Catalonia.
Key inclusion criteria (1 listed)
- Diagnostic of Acute Mesenteric Ischemia
Key exclusion criteria (4 listed)
- Chronic Mesenteric Ischemia
- Ischemic Colitis
- Bowel obstruction strangulation
- Inflammatory bowel necrosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mortality
Time frame: 2024-2026
To describe the mortality in patients with a diagnostic of AMI
2 secondary outcomes
Complications
Time frame: 2024-2026
Management
Time frame: 2024-2026
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2024.
- Derived from this study: PubMed 42154050Gonzalez-Castillo AM, Calsina Juscafresa L, Gelabert A, Velescu A, Marrano E, Vikatmaa P, Tolonen M. The real-world management of acute mesenteric ischemia in Spain: results from a multicenter national survey. Eur J Trauma Emerg Surg. 2026 May 19;52(1):167. doi: 10.1007/s00068-026-03209-1.
Related trials for Acute Mesenteric Ischemia
Recruiting
Evaluation of the Discriminative Abilities of Biomarkers for the Diagnosis of Acute Mesenteric Ischemia Compared With Another Similar Clinical Presentation: a Pilot Study
Acute Mesenteric Ischemia
Active, not recruiting
ThromBus Aspiration for Acute Mesenteric Artery Occlusion With Emergent Laparoscopic Surgery
Acute Mesenteric Ischemia
RecruitingObservational study
Predictors of Transmural Non-Occlusive Mesenteric Ischemia in ICU Patients With Suspected Acute Mesenteric Ischemia
Non-Occlusive Mesenteric Ischaemia (NOMI), Acute Mesenteric Ischemia
RecruitingObservational study
Assessment of Quality of Life After Acute Mesenteric Ischemia
Acute Mesenteric Ischemia
Recruiting
Searching Biomarkers of Acute Intestinal Ischemic Injuries
Acute Mesenteric Ischemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Mesenteric Ischemia, run by Hospital del Mar.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mortality (time frame: 2024-2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06428240, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2024.